Global Allergy Immunotherapy Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 170664
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Medical Devices
Buy @ $3500

The Allergy Immunotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Allergy Immunotherapy size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Allergy Immunotherapy market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Allergy Immunotherapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Subcutaneous Immunotherapy

Sublingual Immunotherapy

Market segment by Application can be divided into

Allergic Rhinitis

Allergic Asthma

Others

The key market players for global Allergy Immunotherapy market are listed below:

ALK-Abello

Stallergenes Greer

Merck

Allergy Therapeutics

HAL

Holister Stier

Leti

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Allergy Immunotherapy product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Allergy Immunotherapy, with price, sales, revenue and global market share of Allergy Immunotherapy in 2018 and 2019.

Chapter 3, the Allergy Immunotherapy competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Allergy Immunotherapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Allergy Immunotherapy market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Allergy Immunotherapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Allergy Immunotherapy Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Allergy Immunotherapy Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Subcutaneous Immunotherapy

1.2.3 Sublingual Immunotherapy

1.3 Market Analysis by Application

1.3.1 Overview: Global Allergy Immunotherapy Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Allergic Rhinitis

1.3.3 Allergic Asthma

1.3.4 Others

1.4 Global Allergy Immunotherapy Market Size & Forecast

1.4.1 Global Allergy Immunotherapy Sales in Value (2016-2026))

1.4.2 Global Allergy Immunotherapy Sales in Volume (2016-2026)

1.4.3 Global Allergy Immunotherapy Price by Type (2016-2026) & (USD/Unit)

1.5 Global Allergy Immunotherapy Production Capacity Analysis

1.5.1 Global Allergy Immunotherapy Total Production Capacity (2016-2026)

1.5.2 Global Allergy Immunotherapy Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Allergy Immunotherapy Market Drivers

1.6.2 Allergy Immunotherapy Market Restraints

1.6.3 Allergy Immunotherapy Trends Analysis

2 Manufacturers Profiles

2.1 ALK-Abello

2.1.1 ALK-Abello Details

2.1.2 ALK-Abello Major Business

2.1.3 ALK-Abello Allergy Immunotherapy Product and Services

2.1.4 ALK-Abello Allergy Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 Stallergenes Greer

2.2.1 Stallergenes Greer Details

2.2.2 Stallergenes Greer Major Business

2.2.3 Stallergenes Greer Allergy Immunotherapy Product and Services

2.2.4 Stallergenes Greer Allergy Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Merck

2.3.1 Merck Details

2.3.2 Merck Major Business

2.3.3 Merck Allergy Immunotherapy Product and Services

2.3.4 Merck Allergy Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Allergy Therapeutics

2.4.1 Allergy Therapeutics Details

2.4.2 Allergy Therapeutics Major Business

2.4.3 Allergy Therapeutics Allergy Immunotherapy Product and Services

2.4.4 Allergy Therapeutics Allergy Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 HAL

2.5.1 HAL Details

2.5.2 HAL Major Business

2.5.3 HAL Allergy Immunotherapy Product and Services

2.5.4 HAL Allergy Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Holister Stier

2.6.1 Holister Stier Details

2.6.2 Holister Stier Major Business

2.6.3 Holister Stier Allergy Immunotherapy Product and Services

2.6.4 Holister Stier Allergy Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Leti

2.7.1 Leti Details

2.7.2 Leti Major Business

2.7.3 Leti Allergy Immunotherapy Product and Services

2.7.4 Leti Allergy Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Allergy Immunotherapy Sales by Manufacturer

3.1 Global Allergy Immunotherapy Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Allergy Immunotherapy Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Allergy Immunotherapy

3.4 Market Concentration Rate

3.4.1 Top 3 Allergy Immunotherapy Manufacturer Market Share

3.4.2 Top 6 Allergy Immunotherapy Manufacturer Market Share

3.5 Global Allergy Immunotherapy Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Allergy Immunotherapy Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Allergy Immunotherapy Market Size by Region

4.1.1 Global Allergy Immunotherapy Sales in Volume by Region (2016-2026)

4.1.2 Global Allergy Immunotherapy Revenue by Region (2016-2026)

4.2 North America Allergy Immunotherapy Revenue (2016-2026)

4.3 Europe Allergy Immunotherapy Revenue (2016-2026)

4.4 Asia-Pacific Allergy Immunotherapy Revenue (2016-2026)

4.5 South America Allergy Immunotherapy Revenue (2016-2026)

4.6 Middle East and Africa Allergy Immunotherapy Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Allergy Immunotherapy Sales in Volume by Type (2016-2026)

5.2 Global Allergy Immunotherapy Revenue by Type (2016-2026)

5.3 Global Allergy Immunotherapy Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Allergy Immunotherapy Sales in Volume by Application (2016-2026)

6.2 Global Allergy Immunotherapy Revenue by Application (2016-2026)

6.3 Global Allergy Immunotherapy Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Allergy Immunotherapy Sales by Type (2016-2026)

7.2 North America Allergy Immunotherapy Sales by Application (2016-2026)

7.3 North America Allergy Immunotherapy Market Size by Country

7.3.1 North America Allergy Immunotherapy Sales in Volume by Country (2016-2026)

7.3.2 North America Allergy Immunotherapy Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Allergy Immunotherapy Sales by Type (2016-2026)

8.2 Europe Allergy Immunotherapy Sales by Application (2016-2026)

8.3 Europe Allergy Immunotherapy Market Size by Country

8.3.1 Europe Allergy Immunotherapy Sales in Volume by Country (2016-2026)

8.3.2 Europe Allergy Immunotherapy Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Allergy Immunotherapy Sales by Type (2016-2026)

9.2 Asia-Pacific Allergy Immunotherapy Sales by Application (2016-2026)

9.3 Asia-Pacific Allergy Immunotherapy Market Size by Region

9.3.1 Asia-Pacific Allergy Immunotherapy Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Allergy Immunotherapy Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Allergy Immunotherapy Sales by Type (2016-2026)

10.2 South America Allergy Immunotherapy Sales by Application (2016-2026)

10.3 South America Allergy Immunotherapy Market Size by Country

10.3.1 South America Allergy Immunotherapy Sales in Volume by Country (2016-2026)

10.3.2 South America Allergy Immunotherapy Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Allergy Immunotherapy Sales by Type (2016-2026)

11.2 Middle East & Africa Allergy Immunotherapy Sales by Application (2016-2026)

11.3 Middle East & Africa Allergy Immunotherapy Market Size by Country

11.3.1 Middle East & Africa Allergy Immunotherapy Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Allergy Immunotherapy Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Allergy Immunotherapy Typical Distributors

12.3 Allergy Immunotherapy Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Allergy Immunotherapy Revenue by Type, (USD Million), 2021-2026

Table 2. Global Allergy Immunotherapy Revenue by Application, (USD Million), 2021-2026

Table 3. ALK-Abello Basic Information, Manufacturing Base and Competitors

Table 4. ALK-Abello Major Business

Table 5. ALK-Abello Allergy Immunotherapy Product and Services

Table 6. ALK-Abello Allergy Immunotherapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Stallergenes Greer Basic Information, Manufacturing Base and Competitors

Table 8. Stallergenes Greer Major Business

Table 9. Stallergenes Greer Allergy Immunotherapy Product and Services

Table 10. Stallergenes Greer Allergy Immunotherapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Merck Basic Information, Manufacturing Base and Competitors

Table 12. Merck Major Business

Table 13. Merck Allergy Immunotherapy Product and Services

Table 14. Merck Allergy Immunotherapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Allergy Therapeutics Basic Information, Manufacturing Base and Competitors

Table 16. Allergy Therapeutics Major Business

Table 17. Allergy Therapeutics Allergy Immunotherapy Product and Services

Table 18. Allergy Therapeutics Allergy Immunotherapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. HAL Basic Information, Manufacturing Base and Competitors

Table 20. HAL Major Business

Table 21. HAL Allergy Immunotherapy Product and Services

Table 22. HAL Allergy Immunotherapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Holister Stier Basic Information, Manufacturing Base and Competitors

Table 24. Holister Stier Major Business

Table 25. Holister Stier Allergy Immunotherapy Product and Services

Table 26. Holister Stier Allergy Immunotherapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Leti Basic Information, Manufacturing Base and Competitors

Table 28. Leti Major Business

Table 29. Leti Allergy Immunotherapy Product and Services

Table 30. Leti Allergy Immunotherapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Global Allergy Immunotherapy Sales by Manufacturer (2019-2021e) & (K Units)

Table 32. Global Allergy Immunotherapy Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 33. Market Position of Manufacturers in Allergy Immunotherapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 34. Global Allergy Immunotherapy Production Capacity by Company, (K Units): 2020 VS 2021

Table 35. Head Office and Allergy Immunotherapy Production Site of Key Manufacturer

Table 36. Allergy Immunotherapy New Entrant and Capacity Expansion Plans

Table 37. Allergy Immunotherapy Mergers & Acquisitions in the Past Five Years

Table 38. Global Allergy Immunotherapy Sales by Region (2016-2021e) & (K Units)

Table 39. Global Allergy Immunotherapy Sales by Region (2021-2026) & (K Units)

Table 40. Global Allergy Immunotherapy Revenue by Region (2016-2021e) & (USD Million)

Table 41. Global Allergy Immunotherapy Revenue by Region (2021-2026) & (USD Million)

Table 42. Global Allergy Immunotherapy Sales by Type (2016-2021e) & (K Units)

Table 43. Global Allergy Immunotherapy Sales by Type (2021-2026) & (K Units)

Table 44. Global Allergy Immunotherapy Revenue by Type (2016-2021e) & (USD Million)

Table 45. Global Allergy Immunotherapy Revenue by Type (2021-2026) & (USD Million)

Table 46. Global Allergy Immunotherapy Price by Type (2016-2021e) & (USD/Unit)

Table 47. Global Allergy Immunotherapy Price by Type (2021-2026) & (USD/Unit)

Table 48. Global Allergy Immunotherapy Sales by Application (2016-2021e) & (K Units)

Table 49. Global Allergy Immunotherapy Sales by Application (2021-2026) & (K Units)

Table 50. Global Allergy Immunotherapy Revenue by Application (2016-2021e) & (USD Million)

Table 51. Global Allergy Immunotherapy Revenue by Application (2021-2026) & (USD Million)

Table 52. Global Allergy Immunotherapy Price by Application (2016-2021e) & (USD/Unit)

Table 53. Global Allergy Immunotherapy Price by Application (2021-2026) & (USD/Unit)

Table 54. North America Allergy Immunotherapy Sales by Country (2016-2021e) & (K Units)

Table 55. North America Allergy Immunotherapy Sales by Country (2021-2026) & (K Units)

Table 56. North America Allergy Immunotherapy Revenue by Country (2016-2021e) & (USD Million)

Table 57. North America Allergy Immunotherapy Revenue by Country (2021-2026) & (USD Million)

Table 58. North America Allergy Immunotherapy Sales by Type (2016-2021e) & (K Units)

Table 59. North America Allergy Immunotherapy Sales by Type (2021-2026) & (K Units)

Table 60. North America Allergy Immunotherapy Sales by Application (2016-2021e) & (K Units)

Table 61. North America Allergy Immunotherapy Sales by Application (2021-2026) & (K Units)

Table 62. Europe Allergy Immunotherapy Sales by Country (2016-2021e) & (K Units)

Table 63. Europe Allergy Immunotherapy Sales by Country (2021-2026) & (K Units)

Table 64. Europe Allergy Immunotherapy Revenue by Country (2016-2021e) & (USD Million)

Table 65. Europe Allergy Immunotherapy Revenue by Country (2021-2026) & (USD Million)

Table 66. Europe Allergy Immunotherapy Sales by Type (2016-2021e) & (K Units)

Table 67. Europe Allergy Immunotherapy Sales by Type (2021-2026) & (K Units)

Table 68. Europe Allergy Immunotherapy Sales by Application (2016-2021e) & (K Units)

Table 69. Europe Allergy Immunotherapy Sales by Application (2021-2026) & (K Units)

Table 70. Asia-Pacific Allergy Immunotherapy Sales by Region (2016-2021e) & (K Units)

Table 71. Asia-Pacific Allergy Immunotherapy Sales by Region (2021-2026) & (K Units)

Table 72. Asia-Pacific Allergy Immunotherapy Revenue by Region (2016-2021e) & (USD Million)

Table 73. Asia-Pacific Allergy Immunotherapy Revenue by Region (2021-2026) & (USD Million)

Table 74. Asia-Pacific Allergy Immunotherapy Sales by Type (2016-2021e) & (K Units)

Table 75. Asia-Pacific Allergy Immunotherapy Sales by Type (2021-2026) & (K Units)

Table 76. Asia-Pacific Allergy Immunotherapy Sales by Application (2016-2021e) & (K Units)

Table 77. Asia-Pacific Allergy Immunotherapy Sales by Application (2021-2026) & (K Units)

Table 78. South America Allergy Immunotherapy Sales by Country (2016-2021e) & (K Units)

Table 79. South America Allergy Immunotherapy Sales by Country (2021-2026) & (K Units)

Table 80. South America Allergy Immunotherapy Revenue by Country (2016-2021e) & (USD Million)

Table 81. South America Allergy Immunotherapy Revenue by Country (2021-2026) & (USD Million)

Table 82. South America Allergy Immunotherapy Sales by Type (2016-2021e) & (K Units)

Table 83. South America Allergy Immunotherapy Sales by Type (2021-2026) & (K Units)

Table 84. South America Allergy Immunotherapy Sales by Application (2016-2021e) & (K Units)

Table 85. South America Allergy Immunotherapy Sales by Application (2021-2026) & (K Units)

Table 86. Middle East & Africa Allergy Immunotherapy Sales by Country (2016-2021e) & (K Units)

Table 87. Middle East & Africa Allergy Immunotherapy Sales by Country (2021-2026) & (K Units)

Table 88. Middle East & Africa Allergy Immunotherapy Revenue by Country (2016-2021e) & (USD Million)

Table 89. Middle East & Africa Allergy Immunotherapy Revenue by Country (2021-2026) & (USD Million)

Table 90. Middle East & Africa Allergy Immunotherapy Sales by Type (2016-2021e) & (K Units)

Table 91. Middle East & Africa Allergy Immunotherapy Sales by Type (2021-2026) & (K Units)

Table 92. Middle East & Africa Allergy Immunotherapy Sales by Application (2016-2021e) & (K Units)

Table 93. Middle East & Africa Allergy Immunotherapy Sales by Application (2021-2026) & (K Units)

Table 94. Direct Channel Pros & Cons

Table 95. Indirect Channel Pros & Cons

Table 96. Allergy Immunotherapy Typical Distributors

Table 97. Allergy Immunotherapy Typical Customers

List of Figures

Figure 1. Allergy Immunotherapy Picture

Figure 2. Global Allergy Immunotherapy Sales Market Share by Type in 2020

Figure 3. Subcutaneous Immunotherapy

Figure 4. Sublingual Immunotherapy

Figure 5. Global Allergy Immunotherapy Sales Market Share by Application in 2020

Figure 6. Allergic Rhinitis

Figure 7. Allergic Asthma

Figure 8. Others

Figure 9. Global Allergy Immunotherapy Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026

Figure 10. Global Allergy Immunotherapy Market Size and Forecast (2016-2026) & (USD Million)

Figure 11. Global Allergy Immunotherapy Sales (2016-2026) & (K Units)

Figure 12. Global Allergy Immunotherapy Price by Type (2016-2026) & (USD/Unit)

Figure 13. Global Allergy Immunotherapy Production Capacity (2016-2026) & (K Units)

Figure 14. Global Allergy Immunotherapy Production Capacity by Geographic Region: 2020 VS 2021

Figure 15. Allergy Immunotherapy Market Drivers

Figure 16. Allergy Immunotherapy Market Restraints

Figure 17. Allergy Immunotherapy Market Trends

Figure 18. Global Allergy Immunotherapy Sales Market Share by Manufacturer in 2020

Figure 19. Global Allergy Immunotherapy Revenue Market Share by Manufacturer in 2020

Figure 20. Allergy Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. Top 3 Allergy Immunotherapy Manufacturer (Revenue) Market Share in 2020

Figure 22. Top 6 Allergy Immunotherapy Manufacturer (Revenue) Market Share in 2020

Figure 23. Global Allergy Immunotherapy Sales Market Share by Region (2016-2026)

Figure 24. Global Allergy Immunotherapy Revenue Market Share by Region (2016-2026)

Figure 25. North America Allergy Immunotherapy Revenue (2016-2026) & (USD Million)

Figure 26. Europe Allergy Immunotherapy Revenue (2016-2026) & (USD Million)

Figure 27. Asia-Pacific Allergy Immunotherapy Revenue (2016-2026) & (USD Million)

Figure 28. South America Allergy Immunotherapy Revenue (2016-2026) & (USD Million)

Figure 29. Middle East & Africa Allergy Immunotherapy Revenue (2016-2026) & (USD Million)

Figure 30. Global Allergy Immunotherapy Sales Market Share by Type (2016-2026)

Figure 31. Global Allergy Immunotherapy Revenue Market Share by Type (2016-2026)

Figure 32. Global Allergy Immunotherapy Price by Type (2016-2026) & (USD/Unit)

Figure 33. Global Allergy Immunotherapy Sales Market Share by Application (2016-2026)

Figure 34. Global Allergy Immunotherapy Revenue Market Share by Application (2016-2026)

Figure 35. Global Allergy Immunotherapy Price by Application (2016-2026) & (USD/Unit)

Figure 36. North America Allergy Immunotherapy Sales Market Share by Type (2016-2026)

Figure 37. North America Allergy Immunotherapy Sales Market Share by Application (2016-2026)

Figure 38. North America Allergy Immunotherapy Sales Market Share by Country (2016-2026)

Figure 39. North America Allergy Immunotherapy Revenue Market Share by Country (2016-2026)

Figure 40. United States Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Canada Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Mexico Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Europe Allergy Immunotherapy Sales Market Share by Type (2016-2026)

Figure 44. Europe Allergy Immunotherapy Sales Market Share by Application (2016-2026)

Figure 45. Europe Allergy Immunotherapy Sales Market Share by Country (2016-2026)

Figure 46. Europe Allergy Immunotherapy Revenue Market Share by Country (2016-2026)

Figure 47. Germany Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. France Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. United Kingdom Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Russia Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Italy Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Asia-Pacific Allergy Immunotherapy Sales Market Share by Region (2016-2026)

Figure 53. Asia-Pacific Allergy Immunotherapy Sales Market Share by Application (2016-2026)

Figure 54. Asia-Pacific Allergy Immunotherapy Sales Market Share by Region (2016-2026)

Figure 55. Asia-Pacific Allergy Immunotherapy Revenue Market Share by Region (2016-2026)

Figure 56. China Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Japan Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Korea Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. India Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Southeast Asia Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Australia Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. South America Allergy Immunotherapy Sales Market Share by Type (2016-2026)

Figure 63. South America Allergy Immunotherapy Sales Market Share by Application (2016-2026)

Figure 64. South America Allergy Immunotherapy Sales Market Share by Country (2016-2026)

Figure 65. South America Allergy Immunotherapy Revenue Market Share by Country (2016-2026)

Figure 66. Brazil Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Argentina Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Middle East & Africa Allergy Immunotherapy Sales Market Share by Type (2016-2026)

Figure 69. Middle East & Africa Allergy Immunotherapy Sales Market Share by Application (2016-2026)

Figure 70. Middle East & Africa Allergy Immunotherapy Sales Market Share by Country (2016-2026)

Figure 71. Middle East & Africa Allergy Immunotherapy Revenue Market Share by Country (2016-2026)

Figure 72. Turkey Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Egypt Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Saudi Arabia Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. South Africa Allergy Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Sales Channel: Direct Channel vs Indirect Channel

Figure 77. Methodology

Figure 78. Research Process and Data Source